Global Osteoarthritis Therapeutics Market 2023-2027

Description

List of Tables

Technavio has been monitoring the osteoarthritis therapeutics market and is forecast to grow by USD 3,962.95 mn during 2022-2027, accelerating at a CAGR of 8.97% during the forecast period. Our report on the osteoarthritis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of osteoarthritis, the availability of guidelines for disease management, and the availability of improved diagnostic modalities.

Technavio's osteoarthritis therapeutics market is segmented as below:

By Product

Analgesics and NSAIDs
Corticosteroids
Viscosupplements
Others

By Type

Ankle osteoarthritis
Hip osteoarthritis
Knee osteoarthritis
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expanding research and development as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years. Also, the rising number of strategic collaborations and advancements in gene therapy and biotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the osteoarthritis therapeutics market covers the following areas:

Osteoarthritis therapeutics market sizing
Osteoarthritis therapeutics market forecast
Osteoarthritis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading osteoarthritis therapeutics market vendors that include Abbott Laboratories, Alvogen Iceland EHF, Anika Therapeutics Inc., Avanos Medical Inc., Bayer AG, Bioventus LLC, Boehringer Ingelheim International GmbH, F. Hoffmann La Roche Ltd., Ferring BV, Fidia Farmaceutici Spa, GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Horizon Therapeutics Plc, Johnson and Johnson, Novartis AG, Pacira BioSciences Inc., Pharmed Ltd., Sanofi SA, Viatris Inc., and Zimmer Biomet Holdings Inc. Also, the osteoarthritis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43212

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global osteoarthritis therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global osteoarthritis therapeutics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Analgesics and NSAIDs - Market size and forecast 2022-2027
Exhibit 34: Chart on Analgesics and NSAIDs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Analgesics and NSAIDs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Analgesics and NSAIDs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Analgesics and NSAIDs - Year-over-year growth 2022-2027 (%)
6.4 Corticosteriods - Market size and forecast 2022-2027
Exhibit 38: Chart on Corticosteriods - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Corticosteriods - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Corticosteriods - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Corticosteriods - Year-over-year growth 2022-2027 (%)
6.5 Viscosupplements - Market size and forecast 2022-2027
Exhibit 42: Chart on Viscosupplements - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Viscosupplements - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Viscosupplements - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Viscosupplements - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 51: Chart on Type - Market share 2022-2027 (%)
Exhibit 52: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 53: Chart on Comparison by Type
Exhibit 54: Data Table on Comparison by Type
7.3 Ankle osteoarthritis - Market size and forecast 2022-2027
Exhibit 55: Chart on Ankle osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Ankle osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Ankle osteoarthritis - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Ankle osteoarthritis - Year-over-year growth 2022-2027 (%)
7.4 Hip osteoarthritis - Market size and forecast 2022-2027
Exhibit 59: Chart on Hip osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Hip osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Hip osteoarthritis - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Hip osteoarthritis - Year-over-year growth 2022-2027 (%)
7.5 Knee osteoarthritis - Market size and forecast 2022-2027
Exhibit 63: Chart on Knee osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Knee osteoarthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Knee osteoarthritis - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Knee osteoarthritis - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Type
Exhibit 71: Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 75: Chart on Geographic comparison
Exhibit 76: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 101: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 113: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 114: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 116: Overview on factors of disruption
11.4 Industry risks
Exhibit 117: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 118: Vendors covered
12.2 Market positioning of vendors
Exhibit 119: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 120: Abbott Laboratories - Overview
Exhibit 121: Abbott Laboratories - Business segments
Exhibit 122: Abbott Laboratories - Key news
Exhibit 123: Abbott Laboratories - Key offerings
Exhibit 124: Abbott Laboratories - Segment focus
12.4 Anika Therapeutics Inc.
Exhibit 125: Anika Therapeutics Inc. - Overview
Exhibit 126: Anika Therapeutics Inc. - Product / Service
Exhibit 127: Anika Therapeutics Inc. - Key offerings
12.5 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.6 Bioventus LLC
Exhibit 133: Bioventus LLC - Overview
Exhibit 134: Bioventus LLC - Business segments
Exhibit 135: Bioventus LLC - Key news
Exhibit 136: Bioventus LLC - Key offerings
Exhibit 137: Bioventus LLC - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 138: Boehringer Ingelheim International GmbH - Overview
Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
Exhibit 140: Boehringer Ingelheim International GmbH - Key news
Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Ferring BV
Exhibit 148: Ferring BV - Overview
Exhibit 149: Ferring BV - Product / Service
Exhibit 150: Ferring BV - Key offerings
12.10 Fidia Farmaceutici Spa
Exhibit 151: Fidia Farmaceutici Spa - Overview
Exhibit 152: Fidia Farmaceutici Spa - Product / Service
Exhibit 153: Fidia Farmaceutici Spa - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 154: GlaxoSmithKline Plc - Overview
Exhibit 155: GlaxoSmithKline Plc - Business segments
Exhibit 156: GlaxoSmithKline Plc - Key offerings
Exhibit 157: GlaxoSmithKline Plc - Segment focus
12.12 Horizon Therapeutics Plc
Exhibit 158: Horizon Therapeutics Plc - Overview
Exhibit 159: Horizon Therapeutics Plc - Business segments
Exhibit 160: Horizon Therapeutics Plc - Key news
Exhibit 161: Horizon Therapeutics Plc - Key offerings
Exhibit 162: Horizon Therapeutics Plc - Segment focus
12.13 Johnson and Johnson
Exhibit 163: Johnson and Johnson - Overview
Exhibit 164: Johnson and Johnson - Business segments
Exhibit 165: Johnson and Johnson - Key news
Exhibit 166: Johnson and Johnson - Key offerings
Exhibit 167: Johnson and Johnson - Segment focus
12.14 Novartis AG
Exhibit 168: Novartis AG - Overview
Exhibit 169: Novartis AG - Business segments
Exhibit 170: Novartis AG - Key offerings
Exhibit 171: Novartis AG - Segment focus
12.15 Sanofi SA
Exhibit 172: Sanofi SA - Overview
Exhibit 173: Sanofi SA - Business segments
Exhibit 174: Sanofi SA - Key news
Exhibit 175: Sanofi SA - Key offerings
Exhibit 176: Sanofi SA - Segment focus
12.16 Viatris Inc.
Exhibit 177: Viatris Inc. - Overview
Exhibit 178: Viatris Inc. - Business segments
Exhibit 179: Viatris Inc. - Key offerings
Exhibit 180: Viatris Inc. - Segment focus
12.17 Zimmer Biomet Holdings Inc.
Exhibit 181: Zimmer Biomet Holdings Inc. - Overview
Exhibit 182: Zimmer Biomet Holdings Inc. - Business segments
Exhibit 183: Zimmer Biomet Holdings Inc. - Key news
Exhibit 184: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 185: Zimmer Biomet Holdings Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 186: Inclusions checklist
Exhibit 187: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 188: Currency conversion rates for US$
13.4 Research methodology
Exhibit 189: Research methodology
Exhibit 190: Validation techniques employed for market sizing
Exhibit 191: Information sources
13.5 List of abbreviations
Exhibit 192: List of abbreviations